Inrig Jula

CHIEF MEDICAL OFFICERTravere Therapeutics, Inc. (TVTX) · full profile →Form 4 · filed May 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Sell(S)311$43.95$14K113K
May 5, 2026Sell(S)2K$46.65$101K114K
May 4, 2026Option exercise(M)4K$0116K
May 4, 2026Option exercise(M)20K$22.40$448K131K
May 4, 2026Sell(S)20K$45.00$900K111K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)20K$035K
May 4, 2026Grant(A)9K$09K
May 4, 2026Option exercise(M)4K$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001902368-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly: